Guru Ownership Trend
Guru Analysis for Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $10.43 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $336,320.68 net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 14.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Sana Biotechnology, Inc. (SANA)
Major holders include Renaissance Technologies (RenTech) ($4.18 M), Cliff Asness ($3.24 M), Paul Tudor Jones ($383,567). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.71 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $336,320.68, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited SANA. The total reported sell value was $719,887.68.
Yes, 1 managers opened new positions in SANA, and 0 increased their existing holdings. The total reported buy value was $383,567.